RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Binance.US Finally Rolls Out Binance Pay Service For US Customers
  2. Analyst On Why Ethereum Flipping Bitcoin Won't Happen Anytime Soon
  3. US Presidential Candidate Pledges Dollar Backing With Bitcoin, No Bitcoin Capital Gains Tax
  4. Dan Tapiero Predicts “Explosive Upmove” For Bitcoin Amid Fed Policy Concerns
  5. BitMEX Co-Founder on Bitcoin and U.S. Banking Crisis